Black Diamond Therapeutics, Inc. — All Filings
463 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001415889-25-002493 | Jan 31, 2025 | Jan 30, 2025 |
| 4 | — | 0001415889-24-029481 | Dec 16, 2024 | Dec 13, 2024 |
| 4 | — | 0001415889-24-029482 | Dec 16, 2024 | Dec 13, 2024 |
| 4 | 4 | 0000950170-24-136739 | Dec 16, 2024 | Dec 13, 2024 |
| SC 13G | BLACK DIAMOND THERAPEUTICS, INC. | 0000902664-24-006560 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001897612-24-001981 | Nov 14, 2024 | — |
| SC 13G | — | 0002012383-24-003406 | Nov 8, 2024 | — |
| 10-Q | 10-Q | 0001701541-24-000042 | Nov 5, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001701541-24-000040 | Nov 5, 2024 | — |
| SC 13G | — | 0002012383-24-002128 | Oct 24, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-106676 | Oct 7, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-101874 | Sep 23, 2024 | — |
| 4 | — | 0001415889-24-023755 | Sep 20, 2024 | — |
| 4 | — | 0001415889-24-023757 | Sep 20, 2024 | — |
| 4 | 4 | 0000950170-24-108430 | Sep 20, 2024 | — |
| 4 | 4 | 0000950170-24-102354 | Aug 30, 2024 | Aug 28, 2024 |
| SC 13D/A | SC 13D/A | 0001193125-24-197045 | Aug 8, 2024 | — |
| 8-K | 8-K | 0001701541-24-000028 | Aug 6, 2024 | — |
| 10-Q | 10-Q | 0001701541-24-000030 | Aug 6, 2024 | Jun 30, 2024 |
| 144 | — | 0001969223-24-000550 | Jul 31, 2024 | — |
| 144 | — | 0001969223-24-000532 | Jul 26, 2024 | — |
| 144 | — | 0001969223-24-000514 | Jul 16, 2024 | — |
| 144 | — | 0001969223-24-000509 | Jul 11, 2024 | — |
| SC 13G/A | — | 0001897612-24-001375 | Jul 10, 2024 | — |
| 144 | — | 0001969223-24-000508 | Jul 9, 2024 | — |
| 144 | — | 0001969223-24-000504 | Jun 28, 2024 | — |
| 144 | — | 0001969223-24-000501 | Jun 27, 2024 | — |
| 144 | — | 0001969223-24-000497 | Jun 26, 2024 | — |
| 144 | — | 0001969223-24-000495 | Jun 24, 2024 | — |
| 144 | — | 0001969223-24-000493 | Jun 21, 2024 | — |
| 4 | — | 0001415889-24-017842 | Jun 21, 2024 | — |
| 4 | 4 | 0000950170-24-076273 | Jun 21, 2024 | — |
| 4 | — | 0001415889-24-017843 | Jun 21, 2024 | — |
| 144 | — | 0001969223-24-000491 | Jun 20, 2024 | — |
| 144 | — | 0001969223-24-000492 | Jun 20, 2024 | — |
| 144 | — | 0001969223-24-000488 | Jun 18, 2024 | — |
| 144 | — | 0001969223-24-000480 | Jun 14, 2024 | — |
| 144 | — | 0001969223-24-000471 | Jun 13, 2024 | — |
| 144 | — | 0001969223-24-000469 | Jun 12, 2024 | — |
| 4 | — | 0001415889-24-015819 | Jun 6, 2024 | — |
| 4 | — | 0001415889-24-015823 | Jun 6, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-069070 | Jun 6, 2024 | — |
| 4 | — | 0001415889-24-015826 | Jun 6, 2024 | — |
| 4 | — | 0001415889-24-015821 | Jun 6, 2024 | — |
| 4 | — | 0001415889-24-015828 | Jun 6, 2024 | — |
| 4 | 4 | 0000950170-24-070044 | Jun 6, 2024 | — |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 16, L.P. / BLACK DIAMOND THERAPEUTICS, INC. -- SCHEDUL | 0001072613-24-000469 | May 13, 2024 | — |
| 10-Q | 10-Q | 0001701541-24-000022 | May 9, 2024 | Mar 31, 2024 |
| 8-K | 8-K | 0001701541-24-000020 | May 9, 2024 | — |
| SC 13D/A | SC 13D/A | 0001104659-24-059533 | May 9, 2024 | — |